Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

318 ARTÍCULOS , VIENDO DEL 241 AL 255

From Alzheimer's disease retrogenesis: a new care strategy for patients with advanced dementia

Venturelli M, Magalini A, Scarsini R, Schena F.

Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):483-9. doi: 10.1177/1533317512459794. Epub 2012 Sep 13.

[Cognitive-behavioral specialized units: predictive factors of readmissions within three months]

Baudemont C, Merlet I, du Boisgueheneuc F, Liuu É, Tartarin F, Ragot S, Paccalin M.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Sep;10(3):277-83. doi: 10.1684/pnv.2012.0366.

The use of errorless learning strategies for patients with Alzheimer's disease: a literature review

Li R, Liu KP.

Int J Rehabil Res. 2012 Dec;35(4):292-8. doi: 10.1097/MRR.0b013e32835a2435.

Relapse risk after discontinuation of risperidone in Alzheimer's disease

Devanand DP, Mintzer J, Schultz SK, Andrews HF, Sultzer DL, de la Pena D, Gupta S, Colon S, Schimming C, Pelton GH, Levin B.

N Engl J Med. 2012 Oct 18;367(16):1497-507. doi: 10.1056/NEJMoa1114058.

[Effectivity of early psychosocial counselling for family caregivers in general practioner based dementia care]

Geschke K, Scheurich A, Schermuly I, Laux N, Böttcher A, Fellgiebel A.

Dtsch Med Wochenschr. 2012 Oct;137(43):2201-6. doi: 10.1055/s-0032-1305320. Epub 2012 Oct 17.

Little hope for medical futility

Caplan AL.

Mayo Clin Proc. 2012 Nov;87(11):1040-1. doi: 10.1016/j.mayocp.2012.09.003.

Vitamin E for Alzheimer's dementia and mild cognitive impairment

Farina N, Isaac MG, Clark AR, Rusted J, Tabet N.

Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD002854. doi: 10.1002/14651858.CD002854.pub3.

Phosphodiesterases as therapeutic targets for Alzheimer's disease

García-Osta A, Cuadrado-Tejedor M, García-Barroso C, Oyarzábal J, Franco R.

ACS Chem Neurosci. 2012 Nov 21;3(11):832-44. doi: 10.1021/cn3000907. Epub 2012 Oct 1.

Alzheimer's dementia: a brief review

Bassil N, Mollaei C.

J Med Liban. 2012 Oct-Dec;60(4):192-9.

Alzheimer's disease: an update

Sharma J.

Nurs J India. 2012 Nov-Dec;103(6):245-8.

[Achetylcholinesterase (AChE) inhibition and serum lipokines in Alzheimer's disease: friend or foe?]

Kovacs J, Pakaski M, Juhasz A, Feher A, Drotos G, Fazekas CO, Horvath TL, Janka Z, Kalman J.

Neuropsychopharmacol Hung. 2012 Mar;14(1):19-27.

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P; Alzheimer’s Disease Cooperative Study.

Arch Neurol. 2012 Jul;69(7):836-41. doi: 10.1001/archneurol.2012.85.

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease

Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E; AAB-001 201/202 Investigators.

Arch Neurol. 2012 Aug;69(8):1002-10. doi: 10.1001/archneurol.2012.90.

Recruitment methods for United States Alzheimer disease prevention trials

Schneider LS.

J Nutr Health Aging. 2012 Apr;16(4):331-5. doi: 10.1007/s12603-012-0011-6.

Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools

Di Carlo M, Giacomazza D, San Biagio PL.

J Phys Condens Matter. 2012 Jun 20;24(24):244102. doi: 10.1088/0953-8984/24/24/244102. Epub 2012 May 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias